Literature DB >> 16368874

Gene expression profiling of diaphragm muscle in alpha2-laminin (merosin)-deficient dy/dy dystrophic mice.

Erik van Lunteren1, Michelle Moyer, Patrick Leahy.   

Abstract

Deficiency of alpha2-laminin (merosin) underlies classical congenital muscular dystrophy in humans and dy/dy muscular dystrophy in mice and causes severe muscle dysfunction in both species. To gain greater insight into the biochemical and molecular events that link alpha2-laminin deficiency with muscle fiber necrosis, and the associated compensatory responses, gene expression profiles were characterized in diaphragm muscle from 8-wk-old dy/dy mice using oligonucleotide microarrays. Compared with age-matched normal muscle, dystrophic diaphragm was characterized by predominantly augmented gene expression, irrespective of the fold-change threshold. Among the 69 genes with at least plus or minus twofold significantly altered expression, 30 belonged to statistically overrepresented Gene Ontology (GO) biological process groups. These covered four specific themes: development including muscle development, cell motility with an emphasis on muscle contraction, defense/immune response, and cell adhesion. An additional 11 gene transcripts were assigned to more general overrepresented GO biological process groups (e.g., cellular process, organismal physiological process); the remaining 28 did not belong to any overrepresented groups. GO cellular constituent assignment resulted in the highest degree of overrepresentation in extracellular and muscle fiber locations, whereas GO molecular function assignment was most notable for various types of binding. RT-PCR was performed on 38 of 41 genes with at least plus or minus twofold significantly altered expression that were assigned to overrepresented GO biological process groups, with expression changes verified for 36 of 38 genes. These results indicate that several specific groups of genes have altered expression in response to genetic alpha2-laminin deficiency, with both similarities and differences compared with data reported for dystrophin-deficient muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368874     DOI: 10.1152/physiolgenomics.00226.2005

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  9 in total

1.  Differential expression of lipid and carbohydrate metabolism genes in upper airway versus diaphragm muscle.

Authors:  Erik van Lunteren; Sarah Spiegler; Michelle Moyer
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

2.  Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle.

Authors:  Katherine E Wardrop; Janice A Dominov
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

Review 3.  Representing ontogeny through ontology: a developmental biologist's guide to the gene ontology.

Authors:  David P Hill; Tanya Z Berardini; Douglas G Howe; Kimberly M Van Auken
Journal:  Mol Reprod Dev       Date:  2010-04       Impact factor: 2.609

4.  Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy.

Authors:  Mattias Häger; Maria Giulia Bigotti; Renata Meszaros; Virginie Carmignac; Johan Holmberg; Valérie Allamand; Mikael Akerlund; Sebastian Kalamajski; Andrea Brancaccio; Ulrike Mayer; Madeleine Durbeej
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

5.  Literature-aided meta-analysis of microarray data: a compendium study on muscle development and disease.

Authors:  Rob Jelier; Peter A C 't Hoen; Ellen Sterrenburg; Johan T den Dunnen; Gert-Jan B van Ommen; Jan A Kors; Barend Mons
Journal:  BMC Bioinformatics       Date:  2008-06-24       Impact factor: 3.169

Review 6.  A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD.

Authors:  Kinga I Gawlik; Madeleine Durbeej
Journal:  Front Mol Neurosci       Date:  2020-04-21       Impact factor: 5.639

7.  Gene expression profiling in the type 1 diabetes rat diaphragm.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

8.  Alterations in lung gene expression in streptozotocin-induced diabetic rats.

Authors:  Erik van Lunteren; Michelle Moyer; Sarah Spiegler
Journal:  BMC Endocr Disord       Date:  2014-01-15       Impact factor: 2.763

9.  Genetic variation regulates opioid-induced respiratory depression in mice.

Authors:  Jason A Bubier; Hao He; Vivek M Philip; Tyler Roy; Christian Monroy Hernandez; Rebecca Bernat; Kevin D Donohue; Bruce F O'Hara; Elissa J Chesler
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.